4-(4-Phenyl-piperazin-1-yl)-butyramide | 197434-85-8

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二嗪烷类
• 英文名称: 4-(4-Phenyl-piperazin-1-yl)-butyramide
• 英文别名: 4-(4-Phenylpiperazin-1-yl)butanamide
• CAS: 197434-85-8
• 化学式: C₁₄H₂₁N₃O
• 分子量: 247.34
• InChiKey: VCGXXWQEWBQBMU-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  18
• 可旋转键数：
  5
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  49.6
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(4-Phenyl-piperazin-1-yl)-butyramide 在 劳森试剂 作用下， 以 甲苯 为溶剂， 反应 2.0h， 生成 4-(4-Phenylpiperazin-1-yl)butanethioamide
  参考文献：
  名称：

  Synthesis of arylpiperazines with a terminal naphthothiazole group and their evaluation on 5-HT, DA and a receptor

  摘要：

  The synthesis, affinities for 5-HT1A, 5-HT2, D-1, D-2, alpha(1) and alpha(2) receptors and structure-activity relationships are described for a series of arylpiperazines substituted on the N-4 atom with an omega-(2-naphthothiazole)alkyl chain. The best affinity for 5-HT1A receptors was obtained for 1-(2-methoxyphenyl)piperazine derivatives with IC50 values in the range 3.2-12 nM; however, for all the reported compounds mixed 5-HT1A/D-2/alpha affinities were observed.

  DOI：

  10.1016/s0223-5234(97)88916-7
• 作为产物：
  描述：

  4-(4-phenylpiperazin-1-yl)butanenitrile 在 硫酸 作用下， 生成 4-(4-Phenyl-piperazin-1-yl)-butyramide
  参考文献：
  名称：

  Synthesis of arylpiperazines with a terminal naphthothiazole group and their evaluation on 5-HT, DA and a receptor

  摘要：

  The synthesis, affinities for 5-HT1A, 5-HT2, D-1, D-2, alpha(1) and alpha(2) receptors and structure-activity relationships are described for a series of arylpiperazines substituted on the N-4 atom with an omega-(2-naphthothiazole)alkyl chain. The best affinity for 5-HT1A receptors was obtained for 1-(2-methoxyphenyl)piperazine derivatives with IC50 values in the range 3.2-12 nM; however, for all the reported compounds mixed 5-HT1A/D-2/alpha affinities were observed.

  DOI：

  10.1016/s0223-5234(97)88916-7

文献信息

• Novel Aryl Piperazine Derivatives With Medical Utility
  申请人：Campiani Giuseppe

  公开号：US20090238761A1

  公开（公告）日：2009-09-24

  This invention provides novel aryl piperazine derivatives having medical utility, in particular as modulators of dopamine and serotonin receptors, preferably the D 3 , D 2 -like and 5-HT 2 receptor subtypes, and in particular useful for the treatment of neuropsychiatric disorders incl. schizophrenia.

  这项发明提供了具有医疗效用的新型芳基哌嗪衍生物，特别是作为多巴胺和5-羟色胺受体的调节剂，优选为D3、D2样和5-HT2受体亚型，特别适用于治疗包括精神分裂症在内的神经精神障碍。
• NOVEL CHROMENE AND THIOCHROMENE CARBOXAMIDE DERIVATIVES, METHODS FOR PREPARING SAME AND THERAPEUTIC APPLICATIONS OF SAME
  申请人：Sokoloff Pierre

  公开号：US20100029682A1

  公开（公告）日：2010-02-04

  The present invention relates to novel chromene or thiochromene carboxamide derivatives, the preparation of same, pharmaceutical compositions of same and the use of same as dopamine D3 ligands as a medicament for central nervous system disorders.

  本发明涉及新型香豆素或硫代香豆素羧酰胺衍生物、其制备方法、相应的药物组成物以及将其用作中枢神经系统疾病的多巴胺D3受体配体的药物。
• COMPOSITIONS, SYNTHESIS, AND METHODS OF UTILIZING QUINAZOLINEDIONE DERIVATIVES
  申请人：Bhat Laxminarayan

  公开号：US20100222359A1

  公开（公告）日：2010-09-02

  The present invention provides quinazolinedione derivatives which can be advantageously used for treating schizophrenia and related psychoses such as acute manic, bipolar disorder, autistic disorder, depression and dementia.

  本发明提供了喹唑啉二酮衍生物，可优势地用于治疗精神分裂症和相关精神病，如急性躁狂、双相障碍、自闭症、抑郁症和痴呆症。
• ARYL PIPERAZINE DERIVATIVES FOR THE TREATMENT OF NEUROPSYCHIATRIC DISORDERS
  申请人：Universita' Degli Studi di Siena

  公开号：EP1836192A2

  公开（公告）日：2007-09-26
• US8575185B2
  申请人：——

  公开号：US8575185B2

  公开（公告）日：2013-11-05